TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30580729

Group type: EXPERIMENTAL
Intervention: Stenting of extracranial lesion during thrombectomy
Number of subjects: 984

Group type: COMPARATOR
Intervention: No stenting of extracranial lesion during thrombectomy
Number of subjects: 984
Study: 30514992

Group type: EXPERIMENTAL
Intervention: Motion therapy procedure
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no motion therapy)
Number of subjects: 200
Study: 27429618

Group type: EXPERIMENTAL
Intervention: Antimicrobial photodynamic therapy in addition to conventional periodontal therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional periodontal therapy
Number of subjects: 40
Study: 24509967

Group type: EXPERIMENTAL
Intervention: Imiquimod 3.75%
Number of subjects: 479

Group type: EXPERIMENTAL
Intervention: Imiquimod 2.5%
Number of subjects: 479

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 479
Study: 23011614

Group type: EXPERIMENTAL
Intervention: Dynamic ultrasound guidance
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Static ultrasound guidance
Number of subjects: 115

Group type: COMPARATOR
Intervention: Landmark technique
Number of subjects: 115
Study: 20478845

Group type: EXPERIMENTAL
Intervention: Endurance exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rest
Number of subjects: 0
Study: 18280326

Group type: EXPERIMENTAL
Intervention: Immediate transfer for PCI
Number of subjects: 600

Group type: COMPARATOR
Intervention: Standard care/rescue PCI
Number of subjects: 600
Study: 15714113

Group type: EXPERIMENTAL
Intervention: Moderate DAS group (n = 10)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Slow DAS group (n = 10)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (n = 10)
Number of subjects: 30
Study: 12784108

Group type: COMPARATOR
Intervention: Estrogen (transdermal administration over 3 days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Testosterone (transdermal administration over 3 days)
Number of subjects: 12
Study: 10647762

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (tinzaparin sodium) given once daily
Number of subjects: 200

Group type: COMPARATOR
Intervention: Intravenous heparin (dose-adjusted)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (tinzaparin sodium)
Number of subjects: 200
Study: 9035508

Group type: EXPERIMENTAL
Intervention: Prednisone for 8 weeks
Number of subjects: 96

Group type: COMPARATOR
Intervention: Prednisone for 12 weeks
Number of subjects: 96
Study: 1391257

Group type: EXPERIMENTAL
Intervention: Freshly frozen plasma infusion (FFP) 10 ml/kg on days 1-3
Number of subjects: 35

Group type: COMPARATOR
Intervention: No FFP
Number of subjects: 35
Study: 4002789

Group type: EXPERIMENTAL
Intervention: muzolimine
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: muzolimine with Aludrox
Number of subjects: 6

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 6
Study: 28608744

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 31027191

Group type: EXPERIMENTAL
Intervention: Combined treatment of vitamin D and aerobic training (DAT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vitamin D (D)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aerobic training (AT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (CTL)
Number of subjects: 0
Study: 27845337

Group type: EXPERIMENTAL
Intervention: Bifidobacterium infantis 35624 (109 c.f.u. per day)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 302
Study: 25406436

Group type: EXPERIMENTAL
Intervention: Positive Online Weight Reduction (POWeR) programme with brief human support
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Positive Online Weight Reduction (POWeR) programme with regular human support
Number of subjects: 0

Group type: COMPARATOR
Intervention: Positive Online Weight Reduction (POWeR) programme
Number of subjects: 0
Study: 24079645

Group type: EXPERIMENTAL
Intervention: Sitagliptin (50 mg/day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combination of mitiglinide and voglibose (1 tablet 3 times daily)
Number of subjects: 20
Study: 21640574

Group type: EXPERIMENTAL
Intervention: Tramadol 100 mg
Number of subjects: 81

Group type: COMPARATOR
Intervention: Indomethacin 100 mg
Number of subjects: 81
Study: 19656087

Group type: EXPERIMENTAL
Intervention: Tirofiban with rescue PCI
Number of subjects: 112

Group type: COMPARATOR
Intervention: Rescue PCI without tirofiban
Number of subjects: 112
Study: 16824852

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (CEE 0.625 mg/d)
Number of subjects: 10739
Study: 15326131

Group type: EXPERIMENTAL
Intervention: Pressure phosphene tonometer (PPT)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Goldmann tonometer (GT)
Number of subjects: 102
Study: 11290865

Group type: EXPERIMENTAL
Intervention: R115777 200 mg/dose, escalated to 300 mg b.i.d. for 28 days
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: R115777 300 mg b.i.d. for 28 days
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: R115777 pharmacokinetics
Number of subjects: 9
Study: 9706365

Group type: EXPERIMENTAL
Intervention: Active recruitment (contacting targeted individuals in person, by phone, or by mail)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Passive recruitment (informing the community through public notices and waiting for volunteers to call)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Passive recruitment
Number of subjects: 126
Study: 7523788

Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 20
Study: 3066417

Group type: EXPERIMENTAL
Intervention: 1 mg oral tablet of lorazepam
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1 mg sublingual tablet of lorazepam
Number of subjects: 12

Group type: COMPARATOR
Intervention: Oral lorazepam
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sublingual lorazepam
Number of subjects: 12
Study: 2250886

Group type: EXPERIMENTAL
Intervention: Lid scrubs and massage for MGD treatment
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control eye (no treatment)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Subjective comfort with contact lens wear after therapy
Number of subjects: 21
Study: 4202264

Group type: EXPERIMENTAL
Intervention: IgG antibodies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Disodium cromoglycate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IgE estimation
Number of subjects: 0
Study: 31384885

Group type: EXPERIMENTAL
Intervention: Prostate specific antigen (PSA) testing intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulation modelling based on data from the European Randomized study of Screening for Prostate Cancer
Number of subjects: 0

Group type: COMPARATOR
Intervention: C-recommendation on screening for prostate cancer
Number of subjects: 0
Study: 27815511

Group type: EXPERIMENTAL
Intervention: Lorcaserin 10 mg once daily (QD)
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Lorcaserin 10 mg twice daily (BID)
Number of subjects: 603

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 603
Study: 25837219

Group type: EXPERIMENTAL
Intervention: Dietary diversity score (DDS) quartiles
Number of subjects: 397
Study: 23523692

Group type: EXPERIMENTAL
Intervention: MK‐0249 10mg
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 21256805

Group type: EXPERIMENTAL
Intervention: Pimavanserin (1, 2.5, 5, or 20 mg)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 18832532

Group type: EXPERIMENTAL
Intervention: Soy-based formula
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed cow's milk protein (CMP), low-lactose formula (PHF)
Number of subjects: 159
Study: 16247575

Group type: EXPERIMENTAL
Intervention: Day-case TEP
Number of subjects: 200

Group type: COMPARATOR
Intervention: Open Lichtenstein hernioplasty
Number of subjects: 200
Study: 15322036

Group type: EXPERIMENTAL
Intervention: PncD/T11 coadministered with DTwP/IPV/PRP-T (whole-cell pertussis)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PncD/T11 coadministered with DTaP/IPV/PRP-T (acellular pertussis)
Number of subjects: 0
Study: 11483802

Group type: EXPERIMENTAL
Intervention: Formula with AA+DHA (egg-DTG)
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Formula with AA+DHA (fish/fungal)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Control formula (no AA or DHA)
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Breastfed infants (reference group)
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Breastfeeding
Number of subjects: 239
Study: 9753527

Group type: EXPERIMENTAL
Intervention: Salmeterol (100 mg daily)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (1 mg daily)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 7820218

Group type: EXPERIMENTAL
Intervention: New onset IDDM
Number of subjects: 20

Group type: COMPARATOR
Intervention: Long-standing IDDM
Number of subjects: 20

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 20
Study: 3337274

Group type: EXPERIMENTAL
Intervention: Clonidine skin patch for 48 hours prior to study
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo skin patch for 48 hours prior to study
Number of subjects: 8
Study: 29234923

Group type: EXPERIMENTAL
Intervention: CRT plus TEM
Number of subjects: 173

Group type: COMPARATOR
Intervention: TME
Number of subjects: 173
Study: 25351282

Group type: EXPERIMENTAL
Intervention: Nintendo Wii intervention
Number of subjects: 10
Study: 26627879

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 5365

Group type: COMPARATOR
Intervention: Enoxaparin/warfarin
Number of subjects: 5365
Study: 23393067

Group type: EXPERIMENTAL
Intervention: Echocardiography
Number of subjects: 22

Group type: COMPARATOR
Intervention: CMR
Number of subjects: 22
Study: 20964660

Group type: EXPERIMENTAL
Intervention: Calcipotriene/betamethasone dipropionate two-compound scalp formulation (n=135)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Vehicle (n=42)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Calcipotriene/betamethasone dipropionate two-compound scalp formulation
Number of subjects: 177

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 177
Study: 18383960

Group type: EXPERIMENTAL
Intervention: Sufentanil 0.2 microg x kg(‐1)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Sufentanil 0.3 microg x kg(‐1)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Sufentanil 0.4 microg x kg(‐1)
Number of subjects: 90
Study: 16331635

Group type: EXPERIMENTAL
Intervention: 4 courses of dose-escalated CHOP plus etoposide (megaCHOEP)
Number of subjects: 84

Group type: COMPARATOR
Intervention: 6 courses of dose-escalated CHOP plus etoposide (megaCHOEP)
Number of subjects: 84
Study: 14616412

Group type: EXPERIMENTAL
Intervention: Voriconazole (200 mg twice daily) + Phenytoin (300 mg once daily)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Voriconazole (400 mg twice daily) + Phenytoin (300 mg once daily)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Phenytoin (300 mg once daily) + Voriconazole (400 mg twice daily)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Voriconazole + Placebo
Number of subjects: 36

Group type: COMPARATOR
Intervention: Phenytoin + Placebo
Number of subjects: 36
Study: 11591255

Group type: EXPERIMENTAL
Intervention: High BMI group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Non-professional hCG administration
Number of subjects: 100
Study: 9160930

Group type: EXPERIMENTAL
Intervention: Randomized controlled trials (RCTs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other controlled trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other analytical studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Descriptive studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: True audits
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall evidence base for otolaryngology
Number of subjects: 0
Study: 7934595

Group type: EXPERIMENTAL
Intervention: Vagus nerve stimulator
Number of subjects: 113
Study: 3251162

Group type: EXPERIMENTAL
Intervention: Metoclopramide (MCP, 30 micrograms/kg/h)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Saline (NaCl 150 mmol/1-50 ml/h)
Number of subjects: 11
Study: 30444856

Group type: EXPERIMENTAL
Intervention: Hypothermia (<36°C)
Number of subjects: 680

Group type: COMPARATOR
Intervention: Normothermia (36‐38.5°C)
Number of subjects: 680
Study: 29176714

Group type: EXPERIMENTAL
Intervention: Acarbose
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glipizide
Number of subjects: 0
Study: 25036417

Group type: EXPERIMENTAL
Intervention: Preoperative education and orientation for scoliosis surgery (PEOSS)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (no preoperative education)
Number of subjects: 65
Study: 23479253

Group type: EXPERIMENTAL
Intervention: Gaze Training (GT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Discovery Learning (DL)
Number of subjects: 36
Study: 20953418

Group type: EXPERIMENTAL
Intervention: Acupuncture (manual and/or electro-stimulation)
Number of subjects: 333

Group type: COMPARATOR
Intervention: No treatment, sham procedure, or usual biomedical care
Number of subjects: 333
Study: 19008099

Group type: EXPERIMENTAL
Intervention: Relaxation training and guided imagery
Number of subjects: 80
Study: 17457567

Group type: EXPERIMENTAL
Intervention: 7-hole titanium compression plate for ulna shortening osteotomy
Number of subjects: 70
Study: 15081441

Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 499

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 499
Study: 11203780

Group type: EXPERIMENTAL
Intervention: Flowable composite (Protect Liner F)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (without flowable composite)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Additional enamel etching with 37% phosphoric acid gel (K-etchant)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (without additional enamel etching)
Number of subjects: 25
Study: 15168719

Group type: EXPERIMENTAL
Intervention: Three-drug combinations of stavudine (d4T), lamivudine (3TC), and indinavir
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Three-drug combinations of d4T, didanosine (ddI), and indinavir
Number of subjects: 0

Group type: COMPARATOR
Intervention: Three-drug combinations of zidovudine (ZDV), 3TC, and indinavir
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two-drug combinations of d4T and 3TC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two-drug combinations of d4T and ddI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two-drug combinations of ZDV and 3TC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two-drug combinations of ZDV and ddI
Number of subjects: 0
Study: 7808748

Group type: EXPERIMENTAL
Intervention: Loratadine (10 mg daily for 3 weeks)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo (1 tablet daily for 8-10 days)
Number of subjects: 41
Study: 2753659

Group type: EXPERIMENTAL
Intervention: Auscultory percussion
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional chest percussion
Number of subjects: 100
Study: 787013

Group type: EXPERIMENTAL
Intervention: Conventional gingivectomy
Number of subjects: 28

Group type: COMPARATOR
Intervention: Non-surgical regime (scaling and oral hygiene instruction)
Number of subjects: 28
Study: 30923105

Group type: EXPERIMENTAL
Intervention: Azacitidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Postremission observation
Number of subjects: 0
Study: 28609330

Group type: EXPERIMENTAL
Intervention: Fan use
Number of subjects: 18
Study: 25956718

Group type: EXPERIMENTAL
Intervention: Restrictive RBC transfusion policy (transfusion when haemoglobin concentration fell below 80 g/L)
Number of subjects: 936

Group type: COMPARATOR
Intervention: Liberal RBC transfusion policy (transfusion when haemoglobin concentration fell below 100 g/L)
Number of subjects: 936

Group type: COMPARATOR
Intervention: Comparison of both policies
Number of subjects: 936
Study: 23364005

Group type: EXPERIMENTAL
Intervention: 5 g n-3 PUFA-containing lipid (70% EPA plus 10% DHA) daily for 3 months
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control lipid
Number of subjects: 79
Study: 21050681

Group type: EXPERIMENTAL
Intervention: Stopped smoking at 1 year
Number of subjects: 1185
Study: 20224148

Group type: EXPERIMENTAL
Intervention: Prebiotic-added formula (0.8 g/dl of a mixture from scGOS and lcFOS, ratio 9:1)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Probiotic-added formula (L. reuteri at dose of 1x10(8) CFU per day)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Breast milk
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo formula
Number of subjects: 49
Study: 17263930

Group type: EXPERIMENTAL
Intervention: Treatment algorithm for hypertension
Number of subjects: 1534

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1534
Study: 15482078

Group type: EXPERIMENTAL
Intervention: Musical mood induction procedures (MMIP) in a negative mood condition for CM drinkers
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Musical mood induction procedures (MMIP) in a positive mood condition for EM drinkers
Number of subjects: 86

Group type: COMPARATOR
Intervention: Positive mood condition (control)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Negative mood condition (control)
Number of subjects: 86
Study: 11678953

Group type: EXPERIMENTAL
Intervention: Pressure applied to nasal mucosa
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Substance P (10 and 80 nmol/mL) applied to nasal mucosa
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Adrenaline (1 : 1000) applied to nasal mucosa
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo applied to nasal mucosa
Number of subjects: 10
Study: 9759745

Group type: EXPERIMENTAL
Intervention: School mental-health programme (4-month duration)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 400
Study: 8782976

Group type: EXPERIMENTAL
Intervention: Monotherapy with one antiepileptic drug
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monotherapy with another antiepileptic drug
Number of subjects: 0
Study: 2200253

Group type: EXPERIMENTAL
Intervention: Nifedipine alone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate plus nifedipine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Isosorbide dinitrate alone
Number of subjects: 12
Study: 6454598

Group type: EXPERIMENTAL
Intervention: Systemic erythromycin stearate
Number of subjects: 56

Group type: COMPARATOR
Intervention: Doxycycline
Number of subjects: 56
Study: 30719933

Group type: EXPERIMENTAL
Intervention: Clinpro 5000
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Clinpro Tooth Crème
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: MI Paste Plus
Number of subjects: 120
Study: 28969592

Group type: EXPERIMENTAL
Intervention: Clinical decision aid
Number of subjects: 397
Study: 25450131

Group type: EXPERIMENTAL
Intervention: Multipath NMES
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional NMES
Number of subjects: 20
Study: 24064440

Group type: EXPERIMENTAL
Intervention: Combined endobronchial and endoscopic ultrasound followed by surgical staging if endoscopy was negative
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgical staging alone
Number of subjects: 0
Study: 23145548

Group type: EXPERIMENTAL
Intervention: D‐efficient experimental design
Number of subjects: 0

Group type: COMPARATOR
Intervention: Orthogonal experimental design
Number of subjects: 0
Study: 20636243

Group type: EXPERIMENTAL
Intervention: 25 microg intravaginal misoprostol every 6 hours for a maximum of four doses
Number of subjects: 240

Group type: COMPARATOR
Intervention: 14-F Foley catheter plus intravenous oxytocin initiated after balloon extrusion or after 24 hours
Number of subjects: 240
Study: 18413703

Group type: EXPERIMENTAL
Intervention: Fluoxetine alone (10‐40 mg/day)
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: CBT alone
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: CBT combined with fluoxetine (10‐40 mg/day)
Number of subjects: 439

Group type: COMPARATOR
Intervention: Placebo (equivalent to 10‐40 mg/day)
Number of subjects: 439
Study: 15837247

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stent (TAXUS stent)
Number of subjects: 1314

Group type: COMPARATOR
Intervention: Bare-metal stent (control)
Number of subjects: 1314

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stent (TAXUS stent) in proximal LAD subgroup
Number of subjects: 1314

Group type: COMPARATOR
Intervention: Bare-metal stent (control) in proximal LAD subgroup
Number of subjects: 1314
Study: 11844743

Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Risedronate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Salmon calcitonin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined antiresorptive therapies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 10357325

Group type: EXPERIMENTAL
Intervention: Clonidine 6 microg/kg orally 120 min before anesthesia and 3 microg/kg IV over the final hour of surgery
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 8817265

Group type: EXPERIMENTAL
Intervention: Controlled, tangential load-forces delivered in an unpredictable manner to the grip surface in contact with the index finger
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Distal loads (away from the palm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proximal loads (toward the palm)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Loads in the direction of gravity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Different hand positions (standard, inverted, horizontally rotated)
Number of subjects: 0
Study: 1445474

Group type: EXPERIMENTAL
Intervention: Drug groups
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 103
Study: 2578649

Group type: EXPERIMENTAL
Intervention: Activity-sensing, rate-responsive pacing (A)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Fixed rate demand pacing (D)
Number of subjects: 6
Study: 31658058

Group type: COMPARATOR
Intervention: Hydromethylthionine at 8 mg/day (control dose)
Number of subjects: 1686

Group type: EXPERIMENTAL
Intervention: Hydromethylthionine at higher doses (4-21 ng/ml)
Number of subjects: 1686

Group type: EXPERIMENTAL
Intervention: Hydromethylthionine at 16 mg/day (predicted optimal dose)
Number of subjects: 1686